Funiver Pharmaceutical Import Profile — El Salvador (DGFT 2022–2026)

Name: Funiver Pharmaceutical Import Records from India — 2 Products, $800.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Funiver — Pharmaceutical Importer Profile (2026) | 2 Products, $800.0K Trade | TransData Nexus

Funiver

Pharmaceutical Importer · El Salvador · Antifungals Focus · $800.0K Total Trade · DGFT Verified

Funiver is a pharmaceutical importer based in El Salvador with a total trade value of $800.0K across 2 products in 2 therapeutic categories. Based on 16 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Funiver sources from 1 verified Indian supplier, with Flamingo Pharmaceuticals Limited accounting for 100.0% of imports.

Funiver — Import Portfolio & Supplier Network

Funiver import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Funiver?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Flamingo Pharmaceuticals Limited	$486.8K	13	100.0%

Funiver sources from 1 verified Indian supplier across 7 distinct formulations. The sourcing is highly concentrated — Flamingo Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Funiver Import?

Formulation	Value	Ships
Gentamicin+betamethasone+clotrimazole	$300.0K	6
Gentamicin betamethasone clotrimazole cream 20g 1s green card no 21168 valid upto 31 03	$100.0K	2
Ciprofloxacin tablets USP 500MG	$36.2K	1
Acetaminophen tablets USP 500MG	$16.5K	1
Amoxicillin for oral suspension USP	$15.0K	1
Mebendazole tablets USP 100MG	$12.2K	1
Indometacin capsules BP 25MG	$6.8K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Clotrimazole	Antifungals	$400.0K	8	0.4%	6
2	Gentamicin	Antibiotics	$400.0K	8	0.8%	4

Funiver imports 2 pharmaceutical products across 2 categories into El Salvador totaling $800.0K.

Funiver — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Funiver, officially known as Laboratorios y Droguería Funiver S.A. de C.V., is a pharmaceutical importer and distributor based in San Salvador, El Salvador. Established in 2013, the company operates from its headquarters at 5ta Avenida Norte y Pasaje Venecia, No. 119, San Salvador. Funiver specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, sourced primarily from India. The company's portfolio is concentrated in two therapeutic categories: antifungals and antibiotics, reflecting a strategic focus on addressing prevalent infectious diseases in the region.

2Distribution Network

Funiver's distribution network is centralized in San Salvador, where it manages warehousing and logistics operations. The company utilizes a centralized distribution model to efficiently supply pharmaceutical products across El Salvador. While specific details about additional warehouse locations or logistics capabilities beyond San Salvador are not publicly available, Funiver's strategic positioning in the capital city suggests a focus on serving the national market effectively.

3Industry Role

In El Salvador's pharmaceutical supply chain, Funiver functions as a primary wholesaler and distributor. By importing finished pharmaceutical formulations from India, the company plays a crucial role in ensuring the availability of essential medications, particularly in the antifungal and antibiotic categories. This positioning enables Funiver to meet the demands of various healthcare providers, including hospitals, clinics, and pharmacies, thereby contributing significantly to the country's healthcare infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Funiver

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Funiver's sourcing strategy exhibits a high degree of concentration, with all 16 shipments from India sourced exclusively from Flamingo Pharmaceuticals Limited, amounting to a total import value of $487,000. This single-source dependency indicates a strategic choice to maintain a consistent supply chain and potentially leverage favorable terms with a trusted supplier. However, such concentration also poses risks, including vulnerability to supply disruptions or changes in supplier dynamics. The absence of alternative suppliers in the current data suggests a need for diversification to mitigate potential risks associated with over-reliance on a single source.

2Supply Chain Resilience

The resilience of Funiver's supply chain is closely tied to its exclusive relationship with Flamingo Pharmaceuticals Limited. While this partnership may offer stability in terms of product quality and consistency, the lack of backup suppliers introduces potential vulnerabilities. The limited diversity in imported formulations, with only seven unique products, further constrains the supply chain's flexibility. Additionally, reliance on a single shipping route and the regulatory compliance of a single supplier heighten the risk of disruptions. To enhance resilience, Funiver may consider diversifying its supplier base and expanding its product portfolio.

Importing Pharmaceuticals into El Salvador — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for El Salvador

1Regulatory Authority & Framework

In El Salvador, the National Directorate of Medicines (Dirección Nacional de Medicamentos, DNM) serves as the primary regulatory authority overseeing pharmaceutical products. The DNM is responsible for the registration, control, and surveillance of medicines, ensuring they meet established quality standards. Pharmaceutical imports are governed by the Law on Administrative Procedures (Decreto No. 856), which outlines the requirements and procedures for importing pharmaceutical products. This legislation mandates that all pharmaceutical products, including those imported, must be registered with the DNM before they can be marketed or distributed within the country.

2Import Licensing & GMP

Import licensing requirements in El Salvador are determined by the DNM. Pharmaceutical products must be registered with the DNM, which involves submitting a special power of attorney authenticated by the Salvadoran consulate or apostilled. (goldservice.com.sv) The DNM recognizes good manufacturing practice (GMP) certificates from countries with drug regulatory agencies certified to Level IV by the Pan American Health Organization (PAHO), as well as those granted by health authorities in the United States, Canada, Australia, Switzerland, Japan, and the European Medicines Agency (EMA). This recognition facilitates the importation of pharmaceutical products from these regions, provided they meet the established GMP standards.

Funiver — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Funiver's focus on importing antifungal and antibiotic formulations aligns with the prevalent healthcare needs in El Salvador, where infectious diseases are a significant public health concern. The strategic selection of these therapeutic areas is driven by market demand for effective treatments against common infections. By concentrating on these categories, Funiver aims to address critical health challenges and establish a strong presence in the pharmaceutical market.

2Sourcing Profile

Funiver's sourcing strategy is centered on importing generic pharmaceutical formulations from India, particularly in the antifungal and antibiotic categories. The company's exclusive relationship with Flamingo Pharmaceuticals Limited indicates a preference for established suppliers that can provide consistent product quality and supply reliability. This approach reflects a strategic decision to maintain a streamlined supply chain and focus on core therapeutic areas that meet the specific needs of the Salvadoran market.

3Market Positioning

Based on its product mix, Funiver primarily serves the wholesale distribution segment of the El Salvadoran pharmaceutical market. By importing and distributing essential medications, the company supplies hospitals, clinics, and pharmacies, thereby playing a pivotal role in ensuring the availability of critical treatments across the country. This positioning underscores Funiver's commitment to enhancing healthcare access and addressing the therapeutic needs of the Salvadoran population.

Seller's Guide — How to Become a Supplier to Funiver

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Funiver, particularly in the areas of antifungal and antibiotic formulations. The existing concentration on a single supplier presents an opportunity for diversification, which could enhance supply chain resilience and product variety. Potential gaps in Funiver's current sourcing include the need for additional formulations or alternative products that complement the existing portfolio, thereby meeting a broader range of patient needs and mitigating risks associated with supplier dependency.

2Requirements & Qualifications

Indian exporters seeking to supply Funiver and the Salvadoran market must ensure that their products are registered with the DNM and comply with the GMP standards recognized by the DNM. Additionally, products must meet the labeling requirements set by the DNM, including Spanish language labeling and inclusion of all mandated information. Exporters should also be prepared to provide a special power of attorney authenticated by the Salvadoran consulate or apostilled to facilitate the registration process. (goldservice.com.sv)

3How to Approach

Frequently Asked Questions — Funiver

What products does Funiver import from India?

Funiver imports 2 pharmaceutical products across 2 categories. Top imports: Clotrimazole ($400.0K), Gentamicin ($400.0K).

Who supplies pharmaceuticals to Funiver from India?

Funiver sources from 1 verified Indian suppliers. The primary supplier is Flamingo Pharmaceuticals Limited (100.0% of imports, $486.8K).

What is Funiver's total pharmaceutical import value?

Funiver's total pharmaceutical import value from India is $800.0K, based on 16 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Funiver focus on?

Funiver imports across 2 categories. The largest: Antifungals (50.0%), Antibiotics (50.0%).

Get Full Funiver Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.